@DanielJDrucker @Guelph From the clinical side: From perspectives (https://t.co/rQNoOrOkVg) and case reports (https://t.co/du8JieYclY) over RCTs (https://t.co/aGU8BHkXna; https://t.co/aDfA5ARy71) to systematic review and individual participant data meta-an
#meds #psychiatry Glucagon-like peptide-1 analogues against antipsychotic- http://t.co/FHPftKk0
Debate in @BMCMedicine: Glucagon-like peptide-1 (#GLP-1) drugs can prevent #antipsychotic induced #weightgain http://t.co/eN0FC9Ah
Debate in @BMCMEDICINE: Glucagon-like peptide-1 (#GLP-1) drugs can prevent #antipsychotic induced #weightgain http://t.co/eN0FC9Ah
RT @bmcmedicine: Latest debate:Glucagon-like peptide-1 (#GLP-1) drugs can prevent #antipsychotic induced #weightgain http://t.co/j175Oi0x
RT @bmcmedicine: Latest debate:Glucagon-like peptide-1 (#GLP-1) drugs can prevent #antipsychotic induced #weightgain http://t.co/j175Oi0x
RT @bmcmedicine: Latest debate:Glucagon-like peptide-1 (#GLP-1) drugs can prevent #antipsychotic induced #weightgain http://t.co/j175Oi0x
RT @bmcmedicine: Latest debate:Glucagon-like peptide-1 (#GLP-1) drugs can prevent #antipsychotic induced #weightgain http://t.co/j175Oi0x
Latest debate:Glucagon-like peptide-1 (#GLP-1) drugs can prevent #antipsychotic induced #weightgain @schizo_news http://t.co/v5dlNZHD
#bmcmedicine Glucagon-like peptide-1 analogues against antipsychotic-induced weight gain: potential physiological .. http://t.co/bkAnrbmM